FuturHealth, a leading provider of personalized weight-loss solutions, today announced the launch of Affirm (NASDAQ: AFRM), ...

Discover a revolutionary approach to mental health as All Access explores Transcranial Magnetic Stimulation (TMS), a non-invasive treatment offering new possibilities for those struggling with ...

SAN DIEGO, March 25, 2025 /PRNewswire/ -- FuturHealth, a leading provider of personalized weight-loss solutions, today announced the launch of Affirm (NASDAQ: AFRM), the payment network that ...

Perez Hilton has struggled with weight management for decades. Now, he’s spreading the word about the benefits of GLP-1 drugs ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay later under a partnership ...

All Access with Andy Garcia, a Public Television program dedicated to exploring groundbreaking innovations, presents a segment featuring FutureHealth TMS. This exploration, titled "Mind Meets ...

Affirm Holdings, Inc. AFRM is expanding its payment solutions with two major partnerships: one with JPMorgan Chase & Co. JPM Payments and a new integration with FuturHealth. These collaborations ...

FuturHealth CEO Luke Mahoney said the partnership gives customers one more option to access the popular glucagon-like peptide-1, or GLP-1, weight-loss drugs. Consumers are struggling to afford ...

If you’re thinking about trying weight loss medication, you probably have a lot of questions about how it works, and how fast ...